Supercharging T-Cells Against HIV’s Weak Spots: A New HIV Vaccine Study Reveals New Hope—and New Challenges—for Aging Patients
June 8, 2026
T-cells are the immune system’s frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demonstrated that new vaccines can...